U.K. centre to develop smart cell processing technologies.
TOKYO, Japan, October 1, 2014 -- Tokyo Electron Limited (TEL) opened an open innovation centre at Stevenage Bioscience Catalyst (SBC) in the U.K.
The goal is to develop standardized smart cell processing technologies for cell culture and inspection through open innovation.
TEL has experience in automation and quality management frameworks in the semiconductor industry, and hopes to transfer of the techniques into life sciences.
Smart cell processing technologies will comprise hardware solutions in the form of equipment for culture and inspection of cells, as well as software algorithms and characterization methods.
TEL will install a fully automated cell culture and inspection system in STC and orchestrates the technology eco-system partners: fifteen companies that will jointly develop smart cell processing technologies to generate a novel system with a shared database and quality management framework to track production processes and ensure cell quality.
TEL will also develop technologies to quantify and standardize cell quality with the National Institute for Biological Standards and Control (NIBSC), as well as stem cell researchers in UK academia.
TEL ultimately plans to develop a vital platform for the U.K. cell therapy industry, working with ecosystem partners, such as the Cell Therapy Catapult and Roslin Cells. The platform is expected to be evaluated for clinical applications in multiple manufacturing sites.
"Our long term goal is to evolve smart cell processing technologies to a fully-automated smart cell factory that can economically and safely produce standardized clinical grade iPS/ES cells," said Yoshio Kinoshita, project leader and director of TEL.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Advanced Stem Cell Technology|
|Publication:||Stem Cell Business News|
|Date:||Oct 6, 2014|
|Previous Article:||ISCO reports on status of Parkinson's disease program.|
|Next Article:||Using skin cells to engineer pulmonary valves for pediatric heart patients.|